WASHINGTON (AP) — The Senate parliamentarian narrowed Democrats' plan for curbing drug costs however left it largely unscathed Saturday, Democrats mentioned, as celebration leaders ready to start out shifting their sprawling financial invoice by way of the chamber.
Elizabeth MacDonough, the chamber's guidelines arbiter, mentioned provisions should be eliminated that may drive drugmakers to pay rebates if their costs rise above inflation for merchandise they promote to non-public insurers.
However pharmaceutical firms must pay these penalties if their costs for medicine purchased by Medicare rise too excessive.
Different elements of the laws, comparable to letting Medicare negotiate prices for the medicine it buys, capping seniors' out-of-pocket bills and offering free vaccines, all survived.
Post a Comment